Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1bKathryn C. Fitzgerald, Alberto Ascherio, Kassandra L. Munger et al.|JAMA Neurology|2015Cited by 169
The 11-year long-term follow-up study from the randomized BENEFIT CIS trialLudwig Kappos, Christine Lebrun‐Frénay, Edward Fox et al.|Neurology|2016Cited by 130
No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFITKassandra L. Munger, Alberto Ascherio, Kathryn C. Fitzgerald et al.|Neurology|2015Cited by 63